Herein, we set out to investigate the role of CpG-ODNs in RKI in cervical cancer and our results found that CpG-ODNs could inactivate the PARP1/XRCC1 axis to prevent RKI in cervical cancer. Here, PARP1 is linked to cervical carcinoma.